Announcements Trials
Browse Landscape

Phase

Phase NA 57Phase 2 23Phase 3 13Phase 1 8Phase 4 4Phase 1/2 3Phase EARLY_PHASE1 2Phase 2/3 2

Status

Completed 3Terminated 2Not yet recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Plasma cell 1Other solid neoplasm 1Other 1

Conditions

Solid Tumor, Adult 1Obesity 1Nutrition Disorders 1Neoplasms 1Multiple Myeloma 1Motor Activity 1Hypertension 1Diabetes Mellitus 1Depression 1Cardiovascular Diseases 1

Interventions

Cyclophosphamide 142Gemcitabine 129Paclitaxel 125Radiotherapy 119Carboplatin 112Cisplatin 111pembrolizumab 110Nivolumab 106Docetaxel 90Rituximab 86Lenalidomide 77Dexamethasone 76Cytarabine 69Bevacizumab 64Fluorouracil 63Etoposide 63Oxaliplatin 62Filgrastim 59Peripheral Blood Stem Cell Transplantation 58Everolimus 58Capecitabine 58fludarabine phosphate 57Doxorubicin 56Temozolomide 55Prednisone 54Irinotecan 53Cetuximab 50fludarabine 48Ipilimumab 48Erlotinib Hydrochloride 48

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1/2 × Completed × Therapeutics × Clear all
NCT04020185 2024-12-11

Safety and Efficacy Study of IMSA101 in Refractory Malignancies

ImmuneSensor Therapeutics Inc.

Phase 1/2 Completed
40 enrolled 16 charts
Other solid neoplasm

Solid Tumor, Adult

NCT01040026 2023-04-04

Expanded Natural Killer (NK) Cells for Multiple Myeloma Study

University Hospital, Basel, Switzerland

Phase 1/2 Completed
10 enrolled
Plasma cell

Multiple Myeloma

NCT03443635 2022-04-29

CHOP

Tulane University

Phase 1/2 Completed
7,192 enrolled 7 charts
Other

Cardiovascular Diseases, Depression, Diabetes Mellitus, Hypertension, Motor Activity, Neoplasms, Nutrition Disorders, Obesity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡